Benztropine 2 mg Tablets — Generic For Cogentin — Leading Pharma

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Benztropine mesylate tablets are a prescription medicine in 0.5 mg, 1 mg, and 2 mg strengths for oral use. The label states that benztropine has anticholinergic and antihistaminic effects, with the anticholinergic effect being the one considered therapeutically important for parkinsonism.

These tablets are indicated as an adjunct treatment for all forms of parkinsonism. They are also used to help control extrapyramidal disorders caused by neuroleptic drugs, except tardive dyskinesia.

The label warns that benztropine may cause side effects such as dry mouth, blurred vision, constipation, urinary retention, drowsiness or confusion, and heat-related problems. It also says the medicine should be used with caution in certain patients, including children over 3 years of age, and should not be used in children under 3 years of age.

Storage Information

Store at 20° to 25° C (68° to 77°F); excursions permitted to 15° to 30° C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in well-closed containers as defined in the USP.

Key Counseling Points

• Take this medicine only as prescribed, and use the dose your healthcare provider recommends.
• The label says the tablets are for oral use.
• This medicine can cause dry mouth, blurred vision, constipation, urinary retention, nausea, or vomiting.
• It may cause mental confusion, excitement, hallucinations, or worsening of mental symptoms in some patients.
• It may impair the mental or physical abilities needed for driving or using machinery.
• Report gastrointestinal complaints, fever, or heat intolerance promptly if this medicine is taken with phenothiazines, haloperidol, or other anticholinergic or antidopaminergic drugs.
• Use caution in hot weather because the medicine may reduce sweating and increase the risk of hyperthermia or heat stroke.
• Do not use this medicine in children under 3 years of age.
• The label says it is not recommended for tardive dyskinesia.
• If side effects occur, the label directs patients to contact a doctor for medical advice.

Helpful Patient Education

Benztropine mesylate tablets USP are available in 0.5 mg, 1 mg, and 2 mg strengths for oral use. According to the DailyMed label, this medicine is used as an adjunct in the therapy of all forms of parkinsonism and may also be used to help control extrapyramidal disorders caused by neuroleptic drugs, except tardive dyskinesia.

Educational product information for benztropine tablets may include key label warnings such as possible dry mouth, blurred vision, constipation, urinary retention, confusion, and heat-related reactions. The label also notes important precautions for children, driving, hot weather, and use with certain other medicines.

Medication Summary last generated: 2026-07-17 02:54:33